Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

40.9K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.9K
Third Law of Thermodynamics02:38

Third Law of Thermodynamics

22.2K
A pure, perfectly crystalline solid possessing no kinetic energy (that is, at a temperature of absolute zero, 0 K) may be described by a single microstate, as its purity, perfect crystallinity,and complete lack of motion means there is but one possible location for each identical atom or molecule comprising the crystal (W = 1). According to the Boltzmann equation, the entropy of this system is zero.
22.2K
Second Law of Thermodynamics02:49

Second Law of Thermodynamics

27.2K
In the quest to identify a property that may reliably predict the spontaneity of a process, a promising candidate has been identified: entropy. Processes that involve an increase in entropy of the system (ΔS > 0) are very often spontaneous; however, examples to the contrary are plentiful. By expanding consideration of entropy changes to include the surroundings, a significant conclusion regarding the relation between this property and spontaneity may be reached. In thermodynamic models, the...
27.2K
Second Law of Thermodynamics00:53

Second Law of Thermodynamics

68.9K
The Second Law of Thermodynamics states that entropy, or the amount of disorder in a system, increases each time energy is transferred or transformed. Each energy transfer results in a certain amount of energy that is lost—usually in the form of heat—that increases the disorder of the surroundings. This can also be demonstrated in a classic food web. Herbivores harvest chemical energy from plants and release heat and carbon dioxide into the environment. Carnivores harvest the...
68.9K
Scientific Laws and Theories02:31

Scientific Laws and Theories

89.5K
Scientific Laws
89.5K
First Law of Thermodynamics00:37

First Law of Thermodynamics

81.2K
The First Law of Thermodynamics states that energy cannot be created or destroyed, only transformed. This can be demonstrated within a classic food web where light energy from the sun is harnessed as radiant energy by plants, converted into chemical energy, and stored as complex carbohydrates. The vegetation is then consumed by animals and during the digestion process, the sugars release energy as heat. The sugars also produce chemical energy that either gets used up doing work, stored in...
81.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photophysical and thermodynamic delineation of binding interactions of anticancer alkaloid chelerythrine towards triplex and duplex DNA structures: a comparative approach.

Physical chemistry chemical physics : PCCP·2026
Same author

Indole-capped gold nanoprisms as multifunctional nano-platforms: DNA binding, mercury sensing, and biological activities.

Physical chemistry chemical physics : PCCP·2026
Same author

In-vitro evaluation of probiotic potential of gut microbes isolated from retail chicken.

PloS one·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Personalized prevention of neurodegenerative diseases: scoping review and evidence gap map.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review.

International journal of molecular sciences·2025
Same journal

Characterization of individuals with skeletal dysplasia at a referral center in Brazil.

Journal of community genetics·2026
Same journal

Experiences of implementation of personalised risk estimates for breast cancer in clinical practice: a systematic review and qualitative synthesis.

Journal of community genetics·2026
Same journal

Sickle cell disease-related myths and misconceptions among tribal communities in India: a multi-state qualitative study.

Journal of community genetics·2026
Same journal

Genetic services in Pakistan: a review highlighting limitations and opportunities for improvement.

Journal of community genetics·2026
Same journal

Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025.

Journal of community genetics·2026
Same journal

Impact of revised severity criteria on the acceptability of PGT-M for childhood-onset cancer predisposition syndromes: a survey of genetic professionals in Japan.

Journal of community genetics·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Risk stratification, genomic data and the law.

Alison Hall1, Thomas Finnegan2, Susmita Chowdhury2

  • 1PHG Foundation, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. alison.hall@phgfoundation.org.

Journal of Community Genetics
|February 23, 2018
PubMed
Summary
This summary is machine-generated.

Genomic data integration in disease risk prediction models faces legal and regulatory hurdles in the EU. Upcoming data protection and in vitro diagnostic device regulations will increase challenges for these personalized medicine tools.

Keywords:
CancerGenomicsLawRisk assessmentStratification

More Related Videos

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
08:31

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'

Published on: May 26, 2013

11.5K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

Related Experiment Videos

Last Updated: Feb 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
08:31

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'

Published on: May 26, 2013

11.5K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

Area of Science:

  • Genomics
  • Bioethics
  • Health Law

Background:

  • Genomic data integration in risk prediction models offers personalized disease prevention.
  • Legal and regulatory implications of using genomic data in these tools remain underexplored.
  • Existing frameworks present modest challenges, classifying genomic data as sensitive.

Purpose of the Study:

  • To explore legal and regulatory perspectives on using genomic data in risk prediction tools.
  • To identify challenges and future implications of these regulations across four EU Member States.
  • To assess the impact of upcoming EU data protection and device regulations.

Main Methods:

  • Workshop convened with legal and regulatory experts from France, Germany, the Netherlands, and the UK.
  • Analysis of current data protection regulations regarding sensitive genomic data.
  • Review of upcoming EU regulations on data protection (effective 2018) and in vitro diagnostic devices (effective 2022).

Main Results:

  • No absolute prohibition exists for using genomic data in risk prediction tools.
  • Current challenges are modest, stemming from genomic data's 'sensitive' classification.
  • Significant future challenges anticipated due to new EU regulations increasing regulatory burden.

Conclusions:

  • Upcoming EU regulations will substantially increase the regulatory burden for genomic risk stratification tools.
  • Failure to address these evolving legal and regulatory challenges could be costly for developers and users.
  • Proactive adaptation to the changing regulatory landscape is crucial for the successful implementation of genomic-based personalized medicine.